pediapharm Chef de file pharmaceutique en pédiatrie au Canada

Canada's Leading Pediatric Pharmaceutical Company

What's new

Pediapharm announces global exclusive licensing agreement for relaxa®, an established canadian product with existing revenues

Read more >

Pediapharm announces participation at the 18th annual rodman & renshaw global investment conference in new york city september 11-13th, 2016

Read more >

Pediapharm announces first quarter financial results – increase of 47% in revenue and operating profit of $1.7 million

Read more >


Stock – PDP.V